Posters And Abstracts Presented at AACR 2021

AACR Poster #1313 – TH1902, a docetaxel peptide-drug conjugate, shows pre-clinical efficacy in several SORT1+ cancers: Click here to view the poster AACR Abstract #1313 – TH1902, a docetaxel peptide-drug conjugate, shows pre-clinical efficacy in several SORT1+ cancers: Click here to view the abstract AACR Poster #1313 Presentation – TH1902, a docetaxel peptide-drug conjugate, shows …Lire la suite

Participation in the Water Tower Research Fireside Chat Series

Paul Levesque, President & Chief Executive Officer and Christian Marsolais, Senior Vice President and Chief Medical Officer, will be participating in the Water Tower Research Fireside Chat Series on Wednesday, February 10th, 2021 at 2:00 p.m. ET.  The event is open to all interested parties. The discussion will focus on TH1902, our lead peptide-drug conjugate …Lire la suite

B. Riley Securities Virtual Oncology Investor Conference

Date and Time: Wednesday, January 20, 2021, 3:30 p.m. ET Presenters:  Paul Levesque, President & CEO, and Christian Marsolais, Senior Vice President and Chief Medical Officer Webcast Link: https://www.webcaster4.com/Webcast/Page/2433/39559 B. Riley Representative: Mayank Mamtani

Recording of the Annual Meeting of Shareholders’ Speeches

Today’s Annual Meeting of Shareholders was mistakenly ended by the operator of the virtual platform after the formal part of the meeting. Speeches from Ms. Dawn Svoronos, Chair of the Board, and Mr. Paul Lévesque, President and Chief Executive Officer, which were supposed to be delivered during the informal part of the meeting, have been …Lire la suite